24H | Springview Rockets Another 16% After a 674% Rally; GPCR Jumps 6% as It Expects Pills to Capture up to 50% of GLP-1 Obesity Market; Hesai Gains 3%

Structure Therapeutics stock jumped about 6% in overnight trading as its CEO expects oral weight-loss pills to capture as much as half of the GLP-1 market by 2030, driven partly by pent-up demand from patients and doctors.

Structure estimates a market of between one and three billion obese and overweight people worldwide for oral weight-loss drugs, CEO Raymond Stevens told Reuters on Wednesday.

Springview Holdings Ltd. stock rose another 16% in overnight trading after unveiling a new clean-energy initiative tied to its Singapore housing business. Shares gained as much as 674% on Thursday. The sharp move reflects heightened investor appetite for small-cap names linked to renewable energy and sustainability themes.

Hesai Group gained another 3%. Shares of Chinese lidar maker Hesai Group could see further upside as the adoption of higher-level autonomous driving systems accelerates in China, Bank of America analysts said in a research note.

BofA said the development of Level 3 advanced driver assistance systems (ADAS) is expected to significantly increase lidar penetration per vehicle, supporting strong volume growth and higher long-term content value for suppliers.